Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

BDX

BECTON DICKINSN

NYSE

Real-time Quotes | Nasdaq Last Sale

246.45

+5.57

+2.31%

After Hours: 246.45 0 0.00% 18:59 03/05 EST

OPEN

241.84

PREV CLOSE

240.88

HIGH

247.61

LOW

240.95

VOLUME

1.11M

TURNOVER

52 WEEK HIGH

284.97

52 WEEK LOW

197.75

MARKET CAP

71.61B

P/E (TTM)

47.37

Becton Dickinson (BDX) Down 3.3% Since Last Earnings Report: Can It Rebound?

Zacks.com · 1d ago

How to Improve The Timing of Investment Decisions in Becton Dickinson $BDX

Mar 05, 2021 (Stock Traders Daily via COMTEX) -- Some people say that timing does not matter, but it does. If you were to buy Becton Dickinson (NYSE: BDX) at...

Stock Traders Daily · 1d ago

Becton Dickinson & Co. stock outperforms competitors despite losses on the day

Shares of Becton Dickinson & Co. slid 0.32% to $240.88 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P...

marketwatch.com · 2d ago

Pharmaceutical Packaging Market Worth USD 153.93 Billion by 2027; Know the COVID-19 Impact Analysis on Pharmaceutical Packaging Industry Worldwide | Fortune Business Insights(TM)

The global pharmaceutical packaging industry is expected to reach USD 153.93 billion by 2027, exhibit a CAGR of 6.4% during the forecast period. The growing adoption of novel and generic drugs in developing countries will have an excellent impact o...

GlobeNewswire · 3d ago

4 Medtech Leaders Have Upcoming Catalysts That Could Be Huge

247WallSt.com · 3d ago

DJ Becton Dickinson Buys Medication-Storage Company GSL Solutions

Dow Jones · 3d ago

BRIEF-BD Acquires GSL Solutions

reuters.com · 3d ago

Becton Dickinson: Terms of the Transaction Were Not Disclosed >BDX

Dow Jones · 3d ago

Forecast

Actual (USD)

Estimate (USD)

Income StatementMore

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

Operating (USD)

YoY (%)

Learn about the latest financial forecast of BDX. Analyze the recent business situations of BECTON DICKINSN through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BDX stock price target is 281.57 with a high estimate of 300.00 and a low estimate of 260.00.

EPS

Institutional Holdings

Institutions: 2.07K

Institutional Holdings: 263.35M

% Owned: 90.64%

Shares Outstanding: 290.56M

TypeInstitutionsShares

Increased

566

15.27M

New

281

1.52M

Decreased

517

17.57M

Sold Out

Performance
Asset Allocation
Dividend History

No Data

Industry

Medical Equipment, Supplies & Distribution

+2.73%

Healthcare Equipment & Supplies

+2.13%

Key Executives

Chairman/Executive Director

Vincent Forlenza

President/Chief Executive Officer/Chief Operating Officer/Director

Thomas Polen

Chief Financial Officer/Executive Vice President/Chief Administrative Officer

Christopher Reidy

Corporate Executive

David Hickey

Executive Vice President/Chief Technology Officer

John DeFord

Chief Human Resource Officer/Executive Vice President/Director of Human Resources

Betty Larson

Corporate Executive

William Tozzi

Executive Vice President/Chief Technology Officer

John Deford

Executive Vice President

Simon Campion

Executive Vice President

Alexandre Conroy

Executive Vice President

Roland Goette

Executive Vice President

Samrat Khichi

Executive Vice President

James Lim

Executive Vice President

Alberto Mas

Chief Accounting Officer/Vice President/Controller

Thomas Spoerel

Lead Director/Independent Director

Marshall Larsen

Independent Director

Catherine Burzik

Independent Director

Christopher Ian Jones

Independent Director

R. Andrew Eckert

Independent Director

Claire Fraser

Independent Director

Jeffrey Henderson

Independent Director

Christopher Jones

Independent Director

David Melcher

Independent Director

Claire Pomeroy

Independent Director

Rebecca Rimel

Independent Director

Timothy Ring

Independent Director

Bertram Scott

Declaration Date Dividend Per Share Ex-Div Date: 01/25/2021
Dividend USD 0.83
03/09/2021; 11/24/2020
Dividend USD 0.83
12/09/2020; 07/27/2020
Dividend USD 0.79
09/08/2020; 04/28/2020
Dividend USD 0.79
06/08/2020; 01/27/2020
Dividend USD 0.79
03/09/2020; 11/25/2019
Dividend USD 0.79
12/09/2019; 07/22/2019
Dividend USD 0.77
09/06/2019; 04/29/2019
Dividend USD 0.77
06/06/2019; 01/21/2019
Dividend USD 0.77
03/07/2019; 11/19/2018
Dividend USD 0.77
12/07/2018; 07/24/2018
Dividend USD 0.75
09/06/2018; 04/23/2018
Dividend USD 0.75
06/07/2018; 01/23/2018
Dividend USD 0.75
03/08/2018; 11/21/2017
Dividend USD 0.75
12/07/2017; 07/27/2017
Dividend USD 0.73
09/07/2017; 05/24/2017
Dividend USD 0.73
06/07/2017; 01/24/2017
Dividend USD 0.73
03/08/2017; 11/22/2016
Dividend USD 0.73
12/07/2016; 07/27/2016
Dividend USD 0.66
09/07/2016; 05/25/2016
Dividend USD 0.66
06/07/2016; 01/26/2016
Dividend USD 0.66
03/08/2016; 11/24/2015
Dividend USD 0.66
12/08/2015; 07/29/2015
Dividend USD 0.6
09/04/2015; 05/20/2015
Dividend USD 0.6
06/05/2015; 01/27/2015
Dividend USD 0.6
03/06/2015; 12/08/2014
Dividend USD 0.6
12/08/2014; 07/22/2014
Dividend USD 0.545
09/05/2014; 05/20/2014
Dividend USD 0.545
06/05/2014; 01/28/2014
Dividend USD 0.545
03/06/2014; 11/26/2013
Dividend USD 0.545
12/06/2013; 07/23/2013
Dividend USD 0.495
09/05/2013

All
Financials
Insiders

About BDX

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Webull offers kinds of Becton Dickinson and Co stock information, including NYSE:BDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BDX stock methods without spending real money on the virtual paper trading platform.